U.S. markets close in 1 hour 53 minutes
  • S&P 500

    4,239.46
    +14.67 (+0.35%)
     
  • Dow 30

    33,911.20
    +34.23 (+0.10%)
     
  • Nasdaq

    14,208.44
    +66.96 (+0.47%)
     
  • Russell 2000

    2,282.35
    -3.74 (-0.16%)
     
  • Crude Oil

    73.04
    -0.62 (-0.84%)
     
  • Gold

    1,778.40
    -4.50 (-0.25%)
     
  • Silver

    25.88
    -0.15 (-0.58%)
     
  • EUR/USD

    1.1942
    +0.0017 (+0.14%)
     
  • 10-Yr Bond

    1.4770
    -0.0070 (-0.47%)
     
  • GBP/USD

    1.3942
    +0.0009 (+0.07%)
     
  • USD/JPY

    110.6860
    +0.3880 (+0.35%)
     
  • BTC-USD

    32,463.70
    +53.01 (+0.16%)
     
  • CMC Crypto 200

    772.53
    -21.80 (-2.74%)
     
  • FTSE 100

    7,090.01
    +27.72 (+0.39%)
     
  • Nikkei 225

    28,884.13
    +873.20 (+3.12%)
     

Baxter in $5 billion bid for Omnicell-sources

  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
·1 min read
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

Dec 8 (Reuters) - Medical supplies provider Baxter International Inc has approached medication management software vendor Omnicell Inc with an offer to acquire it for more than $5 billion, people familiar with the matter said on Tuesday.

There is no certainty that Omnicell will engage in negotiations or that any deal will be reached, the sources said, asking not to be identified because the matter is confidential. Baxter's offer is in excess of $120 per share, one of the sources added.

Baxter and Omnicell did not immediately respond to requests for comment.

(Reporting by Greg Roumeliotis in New York)